Ohio Citizens Demand Their Civil Rights

New Ohio lawsuit re. COVID hoax

COMPLAINT, Michael Renze et al v. Michael DeWine et al, Case No. 3:20-cv-1948, Judge James G. Carr, filed Sep. 01, 2020  (N.D. Ohio, 2020).

Introduction and Prayer for Relief

Over 110 years ago, at a time when medicine was not yet sufficiently advanced to have developed penicillin and the germ theory of medicine was still new, the Supreme Court of the United States made a ruling related to a citizen’s rights in healthcare that has remained largely unaddressed to this day. Over the century plus of time that has since passed the court has decided many critical cases revolving around individual rights that have never been squared with Jacobson.Jacobson v. Massachusetts, 197 U.S. 11 (1905).

A century ago many of our most sacred and fundamental rights were still being sorted out. Suffrage had not yet occurred, civil rights barely existed, critical cases on fundamental rights such as interstate travel and bodily privacy had not come into play and the administrative state that we live in today simply did not exist.

Today, under the guidance of an unelected administrative structure, many of the rights our Supreme Court has determined are fundamental under our Constitution are being denied. These fundamental rights are being denied, not out of prudence, they are being denied due to unfounded fear and intentional manipulation. So successful is this manipulation that even our esteemed Chief Justice, the Honorable Justice Roberts, was misled in a recent decision.

But all is not lost. In its wisdom, the Jacobsoncourt made clear that it never intended its decision to bar further review. To the contrary, the Court in Jacobsonspecifically stated:“Before closing this opinion, we deem it appropriate, in order to prevent misapprehension as to our views, to observe –perhaps to repeat a thought already sufficiently expressed, namely –that the police power of a State, whether exercised by the legislature or by a local body acting under its authority, may be exerted in such circumstances or by regulations so arbitrary and oppressive in particular cases as to justify the interference of the courts to prevent wrong and oppression.” (Id, 197 US 38)

In recent months, entire states have been imprisoned without due process and with the clear threat to impose such lockdowns again, interstate travel has been severely restricted, privacy rights have been devastated, numerous business takings without compensation, and many regulations being implemented without statutory process requirements under the guise of a health emergency that is roughly as dangerous as a seasonal influenza outbreak. The plaintiffs in this case have all been injured in various capacities by these unconstitutional actions, and without action by the Court, will be left without redress.

More terrifying, without action by the Court, the Court will be setting future precedent that will allow states to withhold fundamental Constitutional rights, in violation of US Supreme Court precedent, circumventing the various levels of scrutiny applied to such rights, and justify such actions under public health emergency orders without subjecting those orders to any real review –just trust the bureaucrats because they are the experts.

We humbly ask the Court in this case to:

  1. Reaffirm its position as a coequal branch of the government.

2. Reaffirm the US Constitution is the supreme law of the land and that rights, especially fundamental rights, may not be abridged unless necessary to serve a compelling governmental interest, and that even then, those restrictions must be narrowly tailored to meet acompelling governmental interest.

3. Ensure there is an opportunity for redress under any emergency declaration

4. Recognize that the political process and operative orders are invalid if based on false or misleading information (cite rule making case in admin law) and recognize the criticality that all future emergency orders be based and maintained on clear, honest facts -particularly when such orders are infringing on Constitutional rights.

Underlying all of this, and the foundation of this case is this question: if an emergency can be declared without the appropriate level of review based on the rights being limited, and under the guise of that emergency all rights are only subject to a rational basis review, how then do any previous judicial opinions or Constitutional principles have any meaning whatsoever?

Further, if under the same circumstances different levels of scrutiny are applied to the various rights being limited under an emergency declaration than would otherwise be applicable, what is the value of having various levels of review?

Read the entire complaint here.

Judicially-Recognized Evidence of British Interference in US 2020 Elections

British Health Minister Matt Hancock MP from a long line of Pilgrims Society globalism

British Health Minister Matt Hancock MP who just trashed anti-vaxxers in Parliament yesterday, Sep. 01, 2020, is teaming with Facebook vice president Sir Nick Clegg to attack anti-vaxxers.

Wife’s family is deeply (British) Pilgrims Society, involved in digital, biological and psychological warfare

Comments in Parliament yesterday are an admission of British government interference in the US 2020 elections.

Here’s the actual UK Parliamentary record that is judicially-recognizable evidence in a court proceeding about direct British interference in U.S. election via Facebook & plan to attack vaccine critics

Hancock’s grandfather-in-law was Baron Frederick Millar, a member of the (British) Pilgrims Society and an enemy of a free American Republic

Matthew John David Hancock, MP [WRITTEN]. (Sep. 01, 2020). Question from MP Chris Elmore (Ogmore) re. starting campaign to tackle anti-vaxxers, Nick Clegg, Facebook, The Secretary of State for Health and Social Care (Matt Hancock), Vol. No. 679, Column 23, 3.35 pm. Hansard UK Parliament. https://bit.ly/3lFMfWj

Matthew John David Hancock, MP [VIDEO]. (Sep. 01, 2020). Question from MP Chris Elmore (Ogmore) re. starting campaign to tackle anti-vaxxers, Nick Clegg, Facebook, The Secretary of State for Health and Social Care (Matt Hancock), Vol. No. 679, Column 23, 3.35 pm. Hansard UK Parliament.

.

Rt Hon Matt Hancock MP

Matt Hancock is the Conservative MP for West Suffolk, and has been an MP continuously since 6 May 2010. He currently holds the Government post of Secretary of State for Health and Social Care.

https://members.parliament.uk/member/4070/portrait

Totally unremarkable lucky sperm career in government:

https://members.parliament.uk/member/4070/career

https://en.wikipedia.org/wiki/Matt_Hancock

Grandfather-in-law was:

https://en.wikipedia.org/wiki/Frederick_Millar,_1st_Baron_Inchyra

Globalist extraordinaire—most assuredly a Pilgrims Society member.

During the Second World War he served chiefly at the British embassy in Washington, where he was also Minister Plenipotentiary from 1948 to 1950. Millar was also the United Kingdom Deputy at the North Atlantic Council from 1950 to 1952 and its Representative thereon from 1952 to 1953. The latter year Millar was appointed High Commissioner to the British Zone of occupied Germany, a post he held until 1955, and was then Ambassador to West Germany from 1955 to 1956. After his return to Britain he served as Permanent Under-Secretary at the Foreign Office from 1957 to 1962.

https://members.parliament.uk/member/4070/contributions#expand-3958322

Has a U. S. Citizen Been Attacked by a Foreign Actor Using an Accelerated Particle Beam?

This is very disturbing because it may be an attack on an American citizen by foreign actors. Ashli has a YouTube channel called the DanjA zonE. We watch her videos for entertaining clips of the royal families. Ashli has a unique colorful “scrapbook” style presentation and has a sizeable audience.

Her topics are tabloid-like, but lately they have been getting more controversial. With over 34 million views, she is hardly ‘not noticed’ by folks researching the royals.

Her titles include:

Queen Says Harry Is Mentally Sick

Ghislaine’s Talkin’, Andrew’s Freakin’ & Harry’s a BUTTHEAD

Meghan, Hillary & Michelle Make Powerful Speech on EMPOWERMENT

Lately we have been concerned for Ashli because her titles are getting “splashier” and closer to the viper’s den of the Pilgrims Society, the Monarch, and the Privy Council. It doesn’t appear that Ashli understands how dangerous the situation is right now. Does she know that Buckingham Palace is boarded up and citizens are rioting outside the gates with chants of P – E – D – O?

“Hey Pedos leave our kids alone” | Protesters chant outside Buckingham Palace

Does she know that the enemy of the planet is located with the Queen and the British Imperial Empire?

The enemy knows that somewhere out here in internet land people are waking up about the royals and their crimes. It would be easy to do an internet search and find Ashli’s hundreds of videos. It would be very easy for the enemy to locate her IP address and, by satellite, launch an accelerated particle beam. Listen to her story and pay careful attention to how the houses burst into flames.

Ashli is having to work through some difficult emotions, but she eventually describes the situation clearly.

THANK YOU TO EVERYONE

.

Now look at the damage done to the home.

UPDATE – THANK YOU SO VERY MUCH

Y’all help this sweet woman out by bringing her situation to light with the authorities who can assist the fire department and fire chief in how these fires originated. We may have been attacked by a foreign actor.

Score HCQ by Mail

.

Patriots, push out this information wide and far. This was a great service and the doctors very helpful in answering all of Betsy and Thomas’ questions. The docs were very understanding of folks wanting to protect themselves during these times.

You must circulate this vital info wide and far so that we can protect our “troops>’

God bless you.

Kamala Harris is an illegal alien

Click on headline link to read more intel on Phony Kamala:

Kamala Harris is an illegal alien. She is committing immigration fraud and must be immediately arrested. She is a foreign actor and security threat to the United States Senate and must be removed as a senator.

Senator Kamala Harris does not appear to be an American citizen. Neither parent was American. . . not to mention that Kamala’s Jamaican father Donald Jasper Harris’ Berkeley, California student housing address did not qualify as a “residence and domicile” that would satisfy the 14th Amendment “subject to the jurisdiction thereof” qualifying proviso. Donald’s Jamaican, British & United Nations diplomatic sponsorships actually prohibited Kamala from any citizenship by birth claim pursuant to the precedent-setting case United States v. Wong Kim Ark, 169 U.S. 649 (1898). Conclusion: Short of naturalization, for which no evidence has been presented, Kamala may not even be an American. She was a Jamaican citizen at birth.

 

kamala harris qualifications

Be prepared to have your N.W.O. brainwashing triggered re. the anchor baby question. The subject is off limits for you because that is part of your programming. That is why you have such violent emotional reactions on certain topics, and reject all rational, factual conversation on certain subjects the Tavistock people have determined they need to make you join their side whenever the dog whistle is blown. They have been refining these Tavistock Institute mind control techniques for over 100 years. You aren’t alone.

Push through. You can do it!

There is no such blanket law saying all babies born in the U.S. to foreign parents are automatically citizens.

The test of such citizenship is fact specific and the U.S. Supreme Court established a test in Wong to determine the critical issues of jurisdiction, residence and domicile, along with several other prohibitions, one being a parent being subject to a foreign power, which hindsight shows that Kamala’s U.N. One-World Order father Donald was and still is.

The primary questions in Kamala Harris’ citizenship as having been born of non-US-citizen parents (absent later evidence of naturalization, which she has not provided).

Since her father’s citizenship governs such matters in U.S. law, for certain, the Jamaican Constitution defines her as Jamaican.

Section 3C(b), Citizenship by decent, Jamaica (Constitution) Order in Council 1962. (Jul. 25, 1962). Caribbean and North Atlantic Territories, Statutory Instruments, 1962 No. 1550, Amendments through 2011 appended. Queen Elizabeth and Privy Council.
Section 3C(b), Citizenship by decent, Jamaica (Constitution) Order in Council 1962. (Jul. 25, 1962). Caribbean and North Atlantic Territories, Statutory Instruments, 1962 No. 1550, Amendments through 2011 appended. Queen Elizabeth and Privy Council.

Now, the question is whether she also qualifies as a citizen under U.S. law at the time of birth.

To answer this we must turn to the 14th Amendment and the Supreme Court’s clarification of “jurisdiction” in United States v. Wong Kim Ark, 169 U.S. 649 (1898).

wong kim ark

The Wong Kim Ark decision created a simple test for jurisdiction for which all the elements must be true before it applies:

  1. Child was born in the U.S;
  2. Birth parents are citizens of, and subject to the laws of, a foreign country;
  3. Birth parents have “a permanent domicile and residence in the United States;”
  4. Birth parents “are carrying on business;” and
  5. Birth parents “ are not employed in any diplomatic or official capacity” by the country of their citizenship”

“Domicile and residence” are questions of law important in many subject areas including taxes, custody, citizenship, student scholarships (in-state vs. out-of-state), etc.

Domicile defined:

Mitchell v. United States, 88 US 350 – Supreme Court 1875

domocile

Slaughter-House Cases, 83 US 36 – Supreme Court 1873

Jurisdiction

Miller v. Albright, 523 US 420 – Supreme Court 1998

father child

Adoption of Lindsay C., 229 Cal. App. 3d 404 – Cal: Court of Appeal, 1st Appellate Dist., 3rd Div. 199

domicile 2

Vlandis v. Kline, 412 US 441 – Supreme Court 1973

domicile 3

.

regent street 1

Obvious student housing… a 16 unit apartment

Certainly not a legitimate residence and domicile for citizenship purposes.

https://www.propertyshark.com/mason/Property/38755137/2531-Regent-St-Berkeley-CA-94704/

regent street 2

.

deport kamala harris

.

Michael Voris mistakenly calls Obama black in the video below. Obama is not black. Never was. Indonesian dude – also not qualified for president but SCUMBAG Roberts who gives his allegiance to the Knights of Malta, not the United States, gave him the all-clear to hold the office.

Y’all know that the gallows can hold many traitors? Just line ’em up. Noose ’em up. Drop and haul away. Next line. No different than the 4.5 MILLION people Susan Rice had murdered in the Congo, Sudan, Libya, and Somalia. What? Rice’s life is worth more than anyone of those she murdered?

Air force space command badgeTraitors need to spend some time in the spiritual world reflecting on their past life mistakes here on Earth, from the Rothschilds to the Clintons to ‘the lovers Strzok and Page. They all need to leave Earth now. Perhaps the new space force can help us ‘off-world’ these criminals. They have not been good citizens of our planet. After their “time out”, we welcome them back into their next incarnation where they will be able to make amends to all they have harmed. For Clinton and Rice, that will be a lot of incarnations! Get busy, girls. You have a lot of karma to rectify!

The Vortex — Kamala Family, Slave Owners

What we have here, folks, is an ILLEGAL ALIEN interfering with our election (see meme below). Foreign interference in the 2020 election. Make sure to contact Mike Pompeo to test him and see if he is a TRAITOR or a PATRIOT.

Remember that ‘Pompous’ asked us to send anything we had about foreign interference in our elections. There’s a $10 million reward! Here is one that he cannot ignore, unless Mike Pompeo and his SES staff are TRAITORS. Seriously, AIM Cats. Only ten of you would probably carry out this task…that’s a million each. Get on it! Save your mailing receipts so that we can track and verify to see how fast Pompous moves on this breaking intel.

Bundle up our articles with documentation and citations to show that Kamala Harris is not an American citizen. She is posing as a citizen which is immigration fraud. Furthermore, she must be immediately removed from the Senate because her immigration status is a threat to national security. Put Mike Pompeo on the job, patriots. Let’s see what he does. Remember, as Secretary of State he can fast-track her deportation. But as an SES traitor, he will protect the foreign interloper – Kamala Harris.

‘furtive’ noticed and posted:

Fox News Bret Baier just repeated the BIG LIE:

“Kamala was born in California and she’s a Natural Born Citizen, an all that…anyway who is running Trump’s campaign?”

Another ignoramus afraid to buck his boss.

“ all other persons born within the Republic, of parents owing allegiance to no other sovereignty, are natural born citizens. Gentleman can find no exception to this statement touching natural-born citizens except what is said in the Constitution relating to Indians.” (Cong. Globe, 37th, 2nd Sess., 1639 (1862))

Kamala’s birth parents had allegiances to foreign nations – Jamaica and India. Again, reminding you that her birth father indicated that his race was Jamaican, not African American or Black. Phony Kamala, from head to toe, from birth to present day.

Kamala Devi Harris. (Oct. 20, 1964). Birth Certificate, m. Goplan Shyamala, Caucasian Indian, Age 26, f. Donald Jasper Harris, Age 26, Jamaican, File No. 64-295984, Alameda Cty. Oakland, CA.
Kamala Devi Harris. (Oct. 20, 1964). Birth Certificate, m. Goplan Shyamala, Caucasian Indian, Age 26, f. Donald Jasper Harris, Age 26, Jamaican, File No. 64-295984, Alameda Cty. Oakland, CA.

.

biden harris kamala riot

.

Marie Claire Publication Shills for Kamala Harris

kamala harris afiThe Mockingbird propaganda press today (Aug. 12, 2020) is uniformly pushing out incorrect law about Kamala Harris being an “anchor baby” (sometimes called a “birthright baby”)

See Jenny Hollander. (Aug. 11, 2020). Kamala Harris’ Birthright Citizenship Has Already Spiraled Into a Racist Controversy. Marie Claire writes:

These sites are correctly citing the 14th Amendment, but then incorrectly concluding the meaning of the Constitution on this point of citizenship based on their emotional politics rather than the long precedent.

It takes a leap of logic to interpret the 13th Amendment to allow for citizenship by arguing that a newborn baby is under the jurisdiction of the U.S. at birth merely by virtual of his or her presence in the U.S.

Section 1 of the Fourteenth Amendment to the United States Constitution provides that “All persons born or naturalized in the United States, and subject to the jurisdiction thereof, are citizens of the United States and of the State wherein they reside.”[10]

The U.S. Supreme Court already set up a test of this statute, which all the fake pundits are ignoring.

This interpretation of the law according to Marie Claire’s Jenny Hollander fails the Supreme Court’s United States v. Wong Kim Ark, 169 U.S. 649 (1898) test.

Marie Claire propaganda statement:

marie clair statement

You are so wrong Jenny. Since 1898, the Supreme Court developed a five-pronged test before a person could rely on the 14th Amendment for “birthright” status.

All five prongs must be satisfied to rely on the 14 Amendment.

  1. Child was born in the U.S;
  2. Birth parents are citizens of, and subject to the laws of, a foreign country;
  3. Birth parents have “a permanent domicile and residence in the United States;”
  4. Birth parents “are carrying on business;” and
  5. Birth parents “ are not employed in any diplomatic or official capacity” by the country of their citizenship”

Kamala Harris’s “birthright” test fails (3.) and (4.) for sure, and probably (5.) as well.

Next time Jenny the propagandist, do real homework and don’t just read off your teleprompter and propaganda broadcasts from your Pilgrims Society handlers. You just embarrassed yourself.


Note to readers: Jennie and her clan of lying propagandists report to the folks at the Pilgrims Society. This is their top boss, so to speak. Make sure to register any complaints.

Let them know you aren’t buying this Kamala Harris eligibility narrative being spewed by the propaganda site called Marie Claire and the propagandist ‘reporter’ named Jennie Hollander.

new world order complaintPilgrims addresses

 

U. S. Senator Kamala Harris is not a United States citizen. Demand her deportation immediately.

U.S. Senator Kamala Harris must be arrested and deported immediately for immigration fraud.

Harris was born Oct. 20, 1964. At the time of her birth, her father Donald Jasper Harris, was a citizen of Jamaica, and her mother Gopalan Shyamala, was a citizen of India. Therefore, the laws of both Jamaica and India are clear: Kamala Harris was either a citizen of Jamaica, pursuant to Section 3C(b) of the Constitution of Jamaica, or a citizen of India, pursuant to Part II, Sec. 5 of the Constitution of India.

Section 3C(b), Citizenship by decent, Jamaica (Constitution) Order in Council 1962. (Jul. 25, 1962). Caribbean and North Atlantic Territories, Statutory Instruments, 1962 No. 1550, Amendments through 2011 appended. Queen Elizabeth and Privy Council.
Section 3C(b), Citizenship by decent, Jamaica (Constitution) Order in Council 1962. (Jul. 25, 1962). Caribbean and North Atlantic Territories, Statutory Instruments, 1962 No. 1550, Amendments through 2011 appended. Queen Elizabeth and Privy Council.

.

Part II, Sec. 5, Citizenship. The Constitution of India. (Nov. 9, 2015). Government of India, Ministry of Law and Justice.
Part II, Sec. 5, Citizenship. The Constitution of India. (Nov. 9, 2015). Government of India, Ministry of Law and Justice.

 

Kamala Devi Harris. (Oct. 20, 1964). Birth Certificate, m. Goplan Shyamala, Caucasian Indian, Age 26, f. Donald Jasper Harris, Age 26, Jamaican, File No. 64-295984, Alameda Cty. Oakland, CA.
Kamala Devi Harris. (Oct. 20, 1964). Birth Certificate, Mother: Goplan Shyamala, Caucasian Indian, Age 26; Father: Donald Jasper Harris, Age 26, Jamaican, File No. 64-295984, Alameda County, Oakland, California.

Read more: 

Kamala Harris is a citizen of Jamaica or India, but not the United States

Tyla, Douglas, and Michael explain why Kamala Harris must immediately disclose her naturalization papers. We do not see any proof that she is a United States citizen.

deport Kamala Harris

.

Raw audio file: https://aim4truth.org/wp-content/uploads/2020/08/Deport-Kamala-Harris.mp3

.

 

Moderna Insider Trading Reports

Moderna (NASDAQ: MRNA) insider trading reports (Form 4)

CEO Stephan Bancel

Key officers and directors: Sell, Sell, Sell!

https://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0001682852

Owner Filings Transaction Date Type of Owner
Bancel Stephane 0001443340 2020-07-29 director, officer: Chief Executive Officer
Zaks Tal Zvi 0001690927 2020-07-27 officer: Chief Medical Officer
Hoge Stephen 0001760669 2020-07-23 officer: President
NABEL ELIZABETH G 0001619929 2020-07-15 director
Tallett Elizabeth E 0001192460 2020-07-01 director
HENDERSON LORI M. 0001221127 2020-06-18 officer: General Counsel and Secretary
Meline David W 0001444612 2020-06-08 officer: Chief Financial Officer
Kim Lorence H. 0001643746 2020-06-02 officer: Chief Financial Officer
AFEYAN NOUBAR 0001222012 2020-05-21 director, 10 percent owner
Flagship Ventures Fund IV, L.P. 0001503559 2020-05-21 10 percent owner
Flagship Ventures Fund IV General Partner LLC 0001508051 2020-05-21 director, 10 percent owner
Flagship Ventures Fund IV-Rx, L.P. 0001590973 2020-05-21 10 percent owner
Andres Juan 0001760670 2020-05-13 officer: See remarks
SAGAN PAUL 0001035440 2020-04-29 director
LANGER ROBERT 0001239757 2020-04-29 director
Nader Francois 0001365343 2020-04-29 director
Horning Sandra 0001638709 2020-04-29 director
Slaoui Moncef 0001712369 2020-04-29 director
Berenson Stephen 0001760671 2020-04-29 director
LEE JENNIFER LING 0001675118 2020-03-09 officer: Chief Accounting Officer

moderna 1

Bancel Stephane 0001443340 2020-07-29 director, officer: Chief Executive Officer

https://www.fbcoverup.com/docs/library/2020-07-29-Moderna-Stephane-Bancel-CEO-Sold-$31M-shares-SEC-FORM-4-Jul-29-2020.pdf

stephane bancel

Sold $30,840,614 in shares in her name assigned to Boston Biotech, LLC; Bancel children; OCJA LLC (personal LLC); personally

https://www.crunchbase.com/organization/bb-biotech-ventures

A Zurcih, Switzerland company. Guernsey (offshore) based). Martin Munchbach, Managing Director. Bellevue Asset Management AG.

http://www.bbbiotechventures.com/en/bb-biotech-ventures/

Relationships with Sanofi, Roche, Booz Allen, Genencor, Genzyme, Genentech (Rothschild), Novartis, Ciba-Geigy, Glaxo, Seimens, Hoffman-Roche, Harvard,

. . . . . . .

FYI. Ole Stevie boy has been selling his stock out since Nov. 2019.

No buys. All sells.

https://www.fbcoverup.com/docs/library/2020-08-03-Stephane-Bancel-CEO-Moderna-Inc-Form-D-Insider-Trading-Report-SEC-accessed-Aug-03-2020.pdf

bancel stephane

https://yuzuha.substack.com/p/interview-with-moderna-ceo-stephane

. . . . . . .

Moderna’s latest Proxy Statement Form DEF 14A dated Apr. 10, 2020

Massive Wellcome Trust conflict of interest

Includes numerous conflicting relationships with Goldman Sachs, J.P. Morgan, Wellcome Trust (GlaxoSmithKline – GSK), Harvard, UPenn, Stanford, Merck, Novartis, Sanofi, McKinsey, London School of Economics (notorious promoter of communist ideology), Medtronic, MIT, Dell, Roche, Hoffman-Roche, VMware,

Moderna’s CEO Stephane Bancel and Chief Medical Officer Tal Zaks, MD, Phd have been big stock sellers for a year. Zaks was director of clinical development and translational medice for GLAXOSMITHKLINE (Wellcome Trust – co-owner of the Coronavisur Patent along with the Gates Foundation. THIS CONFLICT IS ALONE IS DISQUALIFYING & FRAUDULENT GIVE GLAXO’S RELATIONSHIP WITH THE PIRBRIGHT INSTITUTE (UK). https://heightzone.com/dr-tal-zaks/

Israeli Tal Zaks – Been only selling his Moderna stock (dumping) since Dec. 2019

This guy is evidently dumping his Moderna shares while he is promoting his supposed COVID vaccine.

That is illegal stock manipulation and should land him and his CEO in jail.

C’mon Bill Barr, do your job.

stephane bancel 2

https://www.sec.gov/Archives/edgar/data/1682852/000119312520103908/d915867ddefa14a.htm

Moderna, Inc. (Filer) CIK0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38753 | Film No.: 20787049
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

MANAGEMENT

Executives, non-executive directors and director nominee

The following table sets forth the name, age and position of each of our executives, non-executive directors and director nominee as of March 2, 2020.

Name Age Position
Executives:
Stéphane Bancel (1) 47 Chief Executive Officer and Director
Juan Andres (1) 55 Chief Technical Operations and Quality Officer
Marcello Damiani 50 Chief Digital and Operational Excellence Officer
Tracey Franklin 40 Chief Human Resources Officer
Lori Henderson, J.D. (1) 58 General Counsel and Corporate Secretary
Stephen Hoge, M.D. (1) 44 President
Lorence Kim, M.D. (1) 45 Chief Financial Officer
Tal Zaks, M.D., Ph.D. (1) 54 Chief Medical Officer
Non-Executive Directors:
Noubar B. Afeyan, Ph.D. (4)(5) 57 Chairman, Director
Stephen Berenson (2)(3) 59 Director
Robert Langer, Sc.D. (4) 71 Director
Elizabeth Nabel, M.D. (4)(5) 68 Director
François Nader, M.D.(5) 63 Director
Israel Ruiz(2)(3) 48 Director
Paul Sagan (2)(3) 61 Director
Moncef Slaoui, Ph.D.(5) 60 Director
Director Nominee:
Sandra Horning, M.D. 71 Director nominee
(1) Executive officer
(2) Member of the Audit Committee
(3) Member of the Compensation and Talent Committee
(4) Member of the Nominating and Corporate Governance Committee
(5) Member of the Product Development Committee

These relationships alone should fundamentally disqualify Moderna or any of its INTERLOCKING relationships from any involvement in Coronavirus.

https://www.sec.gov/Archives/edgar/data/1682852/000119312518341958/d611137ds1a.htm

moderna edgar search

.

moderna registration

“Since we nominated our first program in late 2014, we and our strategic collaborators have advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another 3 have open INDs. Our therapeutic and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. We have assembled an exceptional team of approximately 700 employees and have established strategic alliances with leading biopharmaceutical companies, including AstraZeneca, Merck & Co., and Vertex Pharmaceuticals, as well as government-sponsored and private organizations focused on global health initiatives, including Biomedical Advanced Research and Development Authority, or BARDA, Defense Advanced Research Projects Agency, or DARPA, and the Bill & Melinda Gates Foundation. As of September 30, 2018, we have raised over $2.6 billion in total funding from our strategic collaborators and investors, and have cash, cash equivalents, and investments of $1.2 billion. As we unlock the inherent advantages of mRNA, we aim to address as many diseases and impact as many patients as our technology, talent, and capital permit.”

moderna prospectus summary

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022435/xslF345X03/form4.xml

non derivatives securities 1

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022138/xslF345X03/form4.xml

non derivatives securities 2

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022102/xslF345X03/form4.xml

non derivatives securities 3

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022102/xslF345X03/form4.xml

non derivatives securities 4

https://www.sec.gov/Archives/edgar/data/1443340/000112760220021763/xslF345X03/form4.xml

non derivatives securities 5

https://www.sec.gov/Archives/edgar/data/1443340/000112760220021495/xslF345X03/form4.xml

non derivatives securities 6

https://www.sec.gov/Archives/edgar/data/1443340/000112760220021332/xslF345X03/form4.xml

non derivative security 7

https://www.sec.gov/Archives/edgar/data/1443340/000089924320018777/xslF345X03/doc4.xml

non derivatives securities 8

https://www.sec.gov/Archives/edgar/data/1443340/000112760220020892/xslF345X03/form4.xml

non derivatives securities 9

https://www.sec.gov/Archives/edgar/data/1443340/000110465920079182/xslF345X03/a4.xml

non derivatives securities 10

https://www.sec.gov/Archives/edgar/data/1443340/000112760220020206/xslF345X03/form4.xml

non derivatives 11

https://www.sec.gov/Archives/edgar/data/1443340/000112760220019726/xslF345X03/form4.xml

non derivatives 12

https://www.sec.gov/Archives/edgar/data/1443340/000112760220018531/xslF345X03/form4.xml

non derivatives 13

The above screen captures are but a few of 120 SELLS from late 2019 to current

See full list of Stephane Bancel Form 4 insider trading reports

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001443340

Here’s a full list of the Moderna Insiders

https://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0001682852

moderna insiders

moderna stock exchange

See actual chart entries with hot links above

moderna chart

Bancel Stephane 0001443340 2020-07-29 director, officer: Chief Executive Officer

https://www.fbcoverup.com/docs/library/2020-07-29-Moderna-Stephane-Bancel-CEO-Sold-$31M-shares-SEC-FORM-4-Jul-29-2020.pdf

Sold $30,840,614 in shares in her name assigned to Boston Biotech, LLC; Bancel children; OCJA LLC (personal LLC); personally

https://www.crunchbase.com/organization/bb-biotech-ventures

A Zurich, Switzerland company. Guernsey (offshore) based). Martin Munchbach, Managing Director. Bellevue Asset Management AG.

http://www.bbbiotechventures.com/en/bb-biotech-ventures/

bb biotech

Relationships with Sanofi, Roche, Booz Allen, Genencor, Genzyme, Genentech (Rothschild), Novartis, Ciba-Geigy, Glaxo, Seimens, Hoffman-Roche, Harvard,

.

Executives

Stéphane Bancel has served as our Chief Executive Officer since October 2011 and a member of our board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA (Euronext: BIM). From July 2000 to March 2006, he served in various roles at Eli Lilly and Company (NYSE: LLY), including as Managing Director, Belgium, and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Eli Lilly and Company, Mr. Bancel served as Asia-Pacific Sales and Marketing Director for bioMérieux. Mr. Bancel currently serves on the board of directors of Qiagen N.V. (NYSE: QGEN) and previously served on the boards of directors of BG Medicine, Inc. (OTCMKTS: BGMD) and Syros Pharmaceuticals, Inc. (Nasdaq: SYRS). He is currently a Venture Partner at Flagship Pioneering and a trustee of the Museum of Science in Boston. Mr. Bancel holds a Master of Engineering degree from École Centrale Paris (ECP), a Master of Science in chemical engineering from the University of Minnesota, and an M.B.A. from Harvard Business School. We believe that Mr. Bancel is qualified to serve on our board of directors because of his extensive leadership experience in the healthcare industry and experience as a director of public and private companies.

Juan Andres joined the Company in August 2017, and has served as our Chief Technical Operations and Quality Officer since August 2018. Before joining the Company, Mr. Andres worked at Novartis AG (NYSE: NVS) from

10

Table of Contents

2005 to 2017, in various roles of increasing responsibility including serving as Global Head, Technical Operations (Manufacturing and Supply Chain), Global Head of Quality, and Global Head of Technical Research and Development. From 1987 to 1996, Mr. Andres served in various manufacturing, production, and quality roles at Eli Lilly and Company (NYSE: LLY), including as Vice President, Pharmaceutical Manufacturing. Mr. Andes has served as a member of the board of directors of Evelo Biosciences, Inc. (Nasdaq: EVLO) since December 2019, and of Avantor, Inc. (NYSE: AVTR), since September 2019. Mr. Andres obtained a degree in pharmacy at the Universidad de Alcalá in Spain.

Marcello Damiani joined the Company in May 2015, and has served as our Chief Digital and Operational Excellence Officer since September 2018. From 2009 to 2015, Mr. Damiani held senior roles at bioMérieux (Euronext: BIM), including Senior Vice President and Group Chief Information Officer. Mr. Damiani holds an M.S. degree in Information Systems Architecture from the University of Toulouse, France and completed an international Executive M.B.A. program through TRIUM, an alliance of the London School of Economics, the NYU Stern Business School, and the HEC Paris School of Management, France.

Tracey Franklin has served as our Chief Human Resources Officer since October 2019. From 2004 to October 2019, Ms. Franklin held positions of increasing responsibility at Merck & Co., Inc., including most recently Vice President, HR Chief Talent and Strategy Officer. Ms. Franklin holds a B.A. in communication arts and sciences from Pennsylvania State University and a Masters in industrial and organizational psychology from Fairleigh Dickinson University.

Lori Henderson, J.D., has served as our General Counsel and Corporate Secretary since April 2018. From 2011 to 2018, Ms. Henderson served at Albany Molecular Research Inc. (Nasdaq: AMRI) first as Vice President, General Counsel and Corporate Secretary until 2014 and then as Senior Vice President, General Counsel and Head of Business Development. Prior to her time at AMRI, Ms. Henderson worked as a corporate attorney at Goodwin Procter LLP and as a General Counsel at other corporations. She received her J.D. from the George Washington University Law School and her B.A. in Business and Economics from Gordon College.

Stephen Hoge, M.D., joined the Company in January 2013 and has served as our President since February 2015. From 2010 to 2012, Dr. Hoge was a Partner at McKinsey & Company and a leader in the firm’s healthcare practice. From 2005 to 2010, he served in roles of increasing responsibility at McKinsey & Company. From 2004 to 2005, Dr. Hoge was a resident physician at New York University/Bellevue Hospital. Dr. Hoge has served on the board of directors of Axcella Health, Inc. (Nasdaq: AXLA). He received an M.D. from the University of California, San Francisco and a B.A. in neuroscience from Amherst College.

Lorence Kim, M.D., has served as our Chief Financial Officer since April 2014. From July 2000 to April 2014, Dr. Kim held a number of positions at Goldman, Sachs & Co., most recently as a Managing Director and co-head of biotechnology investment banking. Dr. Kim has served on the board of directors of Seres Therapeutics, Inc. (Nasdaq: MCRB) since 2014. He received an A.B. in Biochemical Sciences from Harvard University, an M.B.A. in Healthcare Management from the Wharton School of the University of Pennsylvania, and an M.D. from the University of Pennsylvania School of Medicine.

Tal Zaks, M.D., Ph.D., has served as our Chief Medical Officer since March 2015. Prior to joining the Company, Dr. Zaks served in senior development positions at Sanofi (NYSE: SNY) from 2010 to 2015, including Senior Vice President and Head of Global Oncology. From July 2008 to May 2010, he served as Vice President of Clinical Research, Oncology at Cephalon. Prior to this, Dr. Zaks spent four years at GlaxoSmithKline (NYSE: GSK) as Director, Clinical Development and Translational Medicine and three years at the National Cancer Institute as a Postdoctoral Fellow. He is currently an Associate Professor of Medicine at the University of Pennsylvania and serves on the board of directors of Adaptimmune Therapeutics plc (Nasdaq: ADAP). Dr. Zaks received his M.D. and Ph.D. from the Ben Gurion University in Israel and conducted post-doctoral research at the U.S. National Institutes of Health. He completed his clinical training in internal medicine at Temple University Hospital followed by a fellowship in medical oncology at the University of Pennsylvania.

11

Table of Contents

Non-executive directors

Noubar B. Afeyan, Ph.D., is a co-founder and has served on our board of directors since incorporation, and has served as a chairman of our board of directors since February 2012. In 1999, Dr. Afeyan founded Flagship Pioneering and serves as its Senior Managing Partner and Chief Executive Officer. Since April 2013, Dr. Afeyan has served on the board of directors of Rubius Therapeutics, Inc. (Nasdaq: RUBY) and since October 2010, on the board of Seres Therapeutics, Inc. (Nasdaq: MCRB). He currently serves on the boards of numerous privately held companies, and has previously served on the boards of numerous privately and publicly held companies, including Evelo Biosciences, Inc. (Nasdaq: EVLO), Kaleido Biosciences, Inc. (Nasdaq: KLDO) and BG Medicine, Inc (OTCMKTS: BGMD). He received a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (“MIT”) and a B.S. in chemical engineering from McGill University. Dr. Afeyan is currently a visiting lecturer of business administration at Harvard Business School and was previously a senior lecturer at MIT’s Sloan School of Management where he taught courses on technology-entrepreneurship, innovation, and leadership. We believe that Dr. Afeyan’s significant experience co-founding, leading, and investing in numerous biotechnology companies make him qualified to serve on our board of directors.

Stephen Berenson has served as a member of our board of directors since October 2017. Mr. Berenson is a Managing Partner at Flagship Pioneering. Prior to that, Mr. Berenson spent 33 years as an investment banker at J.P. Morgan. During his last twelve years at J.P. Morgan, Mr. Berenson was Vice Chairman of Investment Banking and focused on providing high-touch strategic advice and complex transaction execution to leading companies across all industries globally. He was co-founder of J.P. Morgan’s Global Strategic Advisory Council and co-founder of the firm’s Board Initiative. Mr. Berenson also serves as Chairman of the board of directors of Seres Therapeutics, Inc. (Nasdaq: MCRB) and on the board of directors of CiBO Technologies, Inc. Mr. Berenson received an S.B. in mathematics from MIT. We believe that Mr. Berenson is qualified to serve on our board of directors because of his experience in the banking and investment industries.

Robert Langer, Sc.D., has served as a member of our board of directors since December 2010. Dr. Langer has been an Institute Professor at MIT since 2005, and prior to that was a Professor at MIT beginning in 1977. Dr. Langer currently serves on the board of directors of Rubius Therapeutics, Inc. (Nasdaq: RUBY), Kala Pharmaceuticals, Inc. (Nasdaq: KALA), and the UK public company Puretech Health plc (LON: PRTC), and previously served on the board of directors of Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), Wyeth (NYSE: WYE), Fibrocell Science, Inc. (Nasdaq: FCSC) and Millipore Corporation (acquired by Merck KGaA in 2010). Dr. Langer also served as a member of the Science Board to the U.S. Food and Drug Administration from 1995 to 2002, including his service as chairman from 1999 to 2002. Dr. Langer received his B.S. from Cornell University and his Sc.D. from MIT, both in Chemical Engineering. We believe that Dr. Langer is qualified to serve on our board of directors because of his pioneering academic work, extensive medical and scientific knowledge and experience, and his previous service on public company boards of directors.

Elizabeth Nabel, M.D., has served as a member of our board of directors since December 2015. Dr. Nabel has served as President of Harvard University-affiliated Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization, since 2010. Dr. Nabel has also been a Professor of Medicine at Harvard Medical School since 2010. Prior to that, Dr. Nabel held a variety of roles, including Director, at the National Heart, Lung and Blood Institute at the National Institutes of Health, a federal agency funding research, training and education programs to promote the prevention and treatment of heart, lung and blood diseases, from 1999 to 2009. She is an elected member of the National Academy of Medicine of the National Academy of Sciences. Dr. Nabel currently serves on the board of directors of Medtronic plc (NYSE: MDT) and as a trustee of Tekla Capital Management LLC. We believe that Dr. Nabel is qualified to serve on our board of directors because of her extensive experience in the health care field, including senior positions with a number of research universities and organizations.

François Nader, M.D., has served as a member of our board of directors since December 2019. Dr. Nader currently serves as Chairman of the board of directors of Acceleron Pharma Inc. (Nasdaq: XLRN), Prevail

12

Table of Contents

Therapeutics Inc. (Nasdaq: PRVL) and Talaris Therapeutics, Inc. He also serves on the board of directors of Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) and as an advisor for SVB Leerink. Dr. Nader is the past Chairman of BioNJ, New Jersey’s biotechnology trade organization, and previously served on the board of the Biotechnology Industry Organization (BIO), NPS Pharmaceuticals (Nasdaq: NPSP), Advanced Accelerator Applications S.A. (Nasdaq: AAAP), Baxalta Inc. (NYSE: BXLT), Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), Trevena Inc. (Nasdaq: TRVN) and Noven Pharmaceuticals Inc. (Nasdaq: NOVN). Dr. Nader earned his French doctorate in medicine from St. Joseph University in Lebanon and a physician executive M.B.A. from the University of Tennessee. We believe that Dr. Nader is qualified to serve on our board of directors because of his experience in integrated healthcare markets and medical and regulatory affairs and his service on numerous boards of directors.

Israel Ruiz has served as a member of our board of directors since February 2017. Mr. Ruiz has been the Executive Vice President and Treasurer at MIT since 2011. In this role, Mr. Ruiz oversees all principal administrative and financial functions of MIT. Prior to his current role, Mr. Ruiz served as the Vice President for Finance for MIT from 2007 to 2011 and as a principal for MIT’s Office of Budget and Financial Planning from 2001 to 2007. He currently serves on the board of directors of FM Global and previously served on the board of directors of Fortive Corporation (NYSE: FTV). Mr. Ruiz received a degree in industrial and mechanical engineering from the Polytechnic University of Catalonia and a master’s degree from the MIT Sloan School of Management. We believe that Mr. Ruiz is qualified to serve on our board of directors because of his deep financial and accounting experience as the chief financial officer of MIT.

Paul Sagan has served as a member of our board of directors since June 2018. Mr. Sagan has been a Managing Director at General Catalyst Partners, a venture capital firm, since January 2018, and previously served as an Executive In Residence (XIR) since January 2014. From April 2005 to January 2013, Mr. Sagan served as Chief Executive Officer at Akamai Technologies, Inc. (Nasdaq: AKAM) and was President from May 1999 to September 2010 and from October 2011 to January 2013. He was also a director of Akamai Technologies until 2019. Mr. Sagan currently serves on the board of directors of VMware, Inc. (NYSE: VMW) and was a director of EMC from December 2007 until the acquisition by Dell, Inc. in September 2016. Mr. Sagan received his B.S. from the Medill School of Journalism at Northwestern University. We believe that Mr. Sagan is qualified to serve on our board of directors because of his experience and leadership both in the technology and venture capital fields.

Moncef Slaoui, Ph.D., has served as a member of our board of directors since July 2017. Dr. Slaoui joined GlaxoSmithKline Plc (NYSE: GSK) (“GSK”) in 1988, where he engineered the development of a robust vaccines pipeline. He then led worldwide business development for pharmaceutical products before his appointment to lead research and development in 2006. He assumed overall responsibility for GSK’s Oncology Business in 2010, for GSK Vaccines in 2011, and for all Global Franchises in 2012. Dr. Slaoui is Chairman of the board of directors of Galvani Bioelectronics, a company launched in November 2016 that GSK jointly owns with Verily Life Sciences. Dr. Slaoui has advised the U.S. President’s Council of Advisors on Science and Technology, was a member of the Board of the Agency for Science, Technology, & Research until January 2011, the PhRMA Foundation Board from 2008 to 2016, and the Advisory Committee to the Director of the National Institutes of Health from 2011 to 2016. Dr. Slaoui previously served on the board of directors of Intellia Therapeutics Inc. (Nasdaq: NTLA). Dr. Slaoui is also a former Professor of Immunology at the University of Mons, Belgium. Dr. Slaoui received a Ph.D. in Molecular Biology and Immunology from Université Libre de Bruxelles. We believe that Dr. Slaoui is qualified to serve on our board of directors because of his vast experience in the pharmaceutical industry and various leadership positions.

Director nominee

Sandra Horning, M.D., is nominated to serve as a Class II director on our board. Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc., from 2009 until her retirement in 2019. Prior to Roche, Dr. Horning spent 25 years as a practicing oncologist, investigator and tenured professor at the Stanford University School of Medicine, where she remains a professor of medicine emerita. From 2005 to

13

Table of Contents

2006, she served as President of the American Society of Clinical Oncology. From 2015 to 2018, Dr. Horning served on the Foundation Medicine Board of Directors. She currently serves as an advisor to EQRx, Inc. Dr. Horning received her M.D. from the University of Iowa School of Medicine and completed her post-graduate fellowship in Oncology and Cancer Biology at Stanford University. We believe that Dr. Horning is qualified to serve on our board of directors because of her significant experience in the field of oncology and her product development leadership experience.

. . . . . . .

This financial disclosure is from Moderna’s Initial Public Offering (S-1) disclosure filed on Nov. 09, 2018.

It shows the interlocking and seditious relationships that disqualify ALL of these actors in the current Coronavirus Scam-demic… Gates Foundation, DARPA, BARDA, Merck, AstraZeneca (ICI, British government, Queen’s Golden Share) and Moderna’s Israeli chief medical officer Tal Zaks who was a clinical director at GlaxoSmithKline (Wellcome Trust, agent of the Pilgrims Society and the Queen’s Privy Council)

https://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473ds1.htm

.

Breaking News: Just leaked Jan. 08, 1981 PM Margaret Thatcher 10 Downing Street letter shows seditious use of the American Pilgrims Society and Georgetown as instruments of British foreign policy and propaganda

Francis Richards, Foreign and Commonwealth Office (FCO). (Jan. 08, 1981). Prime Minister Margaret Thatcher’s Visit to the United States: Georgetown University, U.S. Pilgrims Society, including Donovan Award. 10 Downing Street.

This is yet more proof that the U.S. members of the Anglo-American (British) Pilgrims Society are all traitors to the United States and its sovereignty. Remember, Pilgrims vice presidents Henry Kissinger and Paul Volcker (2007-2008) were chief orchestrators of the 2008 bank “bailout” scam to enable Pilgrims banks to further consolidate their global power for the takeover of the American Republic.

See: AFI. (Jul. 28, 2020). The Anglo-American (British) Pilgrims Society and its CFR minions used the Marshall Plan, shrouded in anti-communism, to seize control of global banking using Nazi & Japanese stolen gold. Americans for Innovation.

thatcher 1

thatcher 2

thatcher 3

.